[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Rare Disease Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024

July 2019 | 140 pages | ID: R7209093910DEN
Prof Research

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Rare Disease Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Rare Disease Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rare Disease Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Rare Disease Drug market covering all important parameters.

The key ponits of the report:

1. The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2. The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3. Through the statistical analysis, the report depicts the global and Chinese total market of Rare Disease Drug industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5. The report then estimates 2019-2024 market development trends of Rare Disease Drug industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6. The report makes some important proposals for a new project of Rare Disease Drug Industry before evaluating its feasibility.

There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.

For competitor segment, the report includes global key players of Rare Disease Drug as well as some small players. At least 10 companies are included:
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • Pfizer
  • Sanofi S. A.
For complete companies list, please ask for sample pages.

The information for each competitor includes:
  • Company Profile
  • Main Business Information
  • SWOT Analysis
  • Sales, Revenue, Price and Gross Margin
  • Market Share
For product type segment, this report listed main product type of Rare Disease Drug market in gloabal and china.
  • >1???
  • 0. 65??????1???
  • <0. 1???
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
  • Hospital Pharmacies
  • Speciality Pharmacies
  • Retail pharmacies
  • Others
Reasons to Purchase this Report:
  • Estimates 2019-2024 Rare Disease Drug market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
CHAPTER ONE INTRODUCTION OF RARE DISEASE DRUG INDUSTRY

1.1 Brief Introduction of Rare Disease Drug
1.2 Development of Rare Disease Drug Industry
1.3 Status of Rare Disease Drug Industry

CHAPTER TWO MANUFACTURING TECHNOLOGY OF RARE DISEASE DRUG

2.1 Development of Rare Disease Drug Manufacturing Technology
2.2 Analysis of Rare Disease Drug Manufacturing Technology
2.3 Trends of Rare Disease Drug Manufacturing Technology

CHAPTER THREE ANALYSIS OF GLOBAL KEY MANUFACTURERS

3.1 Novartis AG
  3.1.1 Company Profile
  3.1.2 Product Information
  3.1.3 2014-2019 Production Information
  3.1.4 Contact Information
3.2 Bristol-Myers Squibb Company
  3.2.1 Company Profile
  3.2.2 Product Information
  3.2.3 2014-2019 Production Information
  3.2.4 Contact Information
3.3 Celgene Corporation
  3.2.1 Company Profile
  3.3.2 Product Information
  3.3.3 2014-2019 Production Information
  3.3.4 Contact Information
3.4 F. Hoffmann-La Roche Ltd.
  3.4.1 Company Profile
  3.4.2 Product Information
  3.4.3 2014-2019 Production Information
  3.4.4 Contact Information
3.5 Pfizer
  3.5.1 Company Profile
  3.5.2 Product Information
  3.5.3 2014-2019 Production Information
  3.5.4 Contact Information
3.6 Sanofi S.A.
  3.6.1 Company Profile
  3.6.2 Product Information
  3.5.3 2014-2019 Production Information
  3.6.4 Contact Information
3.7 Alexion Pharmaceuticals
  3.7.1 Company Profile
  3.7.2 Product Information
  3.7.3 2014-2019 Production Information
  3.7.4 Contact Information
3.8 Company H
  3.8.1 Company Profile
  3.8.2 Product Information
  3.8.3 2014-2019 Production Information
  3.8.4 Contact Information

CHAPTER FOUR 2014-2019 GLOBAL AND CHINESE MARKET OF RARE DISEASE DRUG

4.1 2014-2019 Global Capacity, Production and Production Value of Rare Disease Drug Industry
4.2 2014-2019 Global Cost and Profit of Rare Disease Drug Industry
4.3 Market Comparison of Global and Chinese Rare Disease Drug Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Rare Disease Drug
4.5 2014-2019 Chinese Import and Export of Rare Disease Drug

CHAPTER FIVE MARKET STATUS OF RARE DISEASE DRUG INDUSTRY

5.1 Market Competition of Rare Disease Drug Industry by Company
5.2 Market Competition of Rare Disease Drug Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Rare Disease Drug Consumption by Application/Type

CHAPTER SIX 2019-2024 MARKET FORECAST OF GLOBAL AND CHINESE RARE DISEASE DRUG INDUSTRY

6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Rare Disease Drug
6.2 2019-2024 Rare Disease Drug Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Rare Disease Drug
6.4 2019-2024 Global and Chinese Supply and Consumption of Rare Disease Drug
6.5 2019-2024 Chinese Import and Export of Rare Disease Drug

CHAPTER SEVEN ANALYSIS OF RARE DISEASE DRUG INDUSTRY CHAIN

7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry

CHAPTER EIGHT GLOBAL AND CHINESE ECONOMIC IMPACT ON RARE DISEASE DRUG INDUSTRY

8.1 Global and Chinese Macroeconomic Environment Analysis
  8.1.1 Global Macroeconomic Analysis
  8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
  8.2.1 Global Macroeconomic Outlook
  8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Rare Disease Drug Industry

CHAPTER NINE MARKET DYNAMICS OF RARE DISEASE DRUG INDUSTRY

9.1 Rare Disease Drug Industry News
9.2 Rare Disease Drug Industry Development Challenges
9.3 Rare Disease Drug Industry Development Opportunities

CHAPTER TEN PROPOSALS FOR NEW PROJECT

10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment

CHAPTER ELEVEN RESEARCH CONCLUSIONS OF GLOBAL AND CHINESE RARE DISEASE DRUG INDUSTRY

TABLES AND FIGURES

Figure Rare Disease Drug Product Picture
Table Development of Rare Disease Drug Manufacturing Technology
Figure Manufacturing Process of Rare Disease Drug
Table Trends of Rare Disease Drug Manufacturing Technology
Figure Rare Disease Drug Product and Specifications
Table 2014-2019 Rare Disease Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Rare Disease Drug Capacity Production and Growth Rate
Figure 2014-2019 Rare Disease Drug Production Global Market Share
Figure Rare Disease Drug Product and Specifications
Table 2014-2019 Rare Disease Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Rare Disease Drug Capacity Production and Growth Rate
Figure 2014-2019 Rare Disease Drug Production Global Market Share
Figure Rare Disease Drug Product and Specifications
Table 2014-2019 Rare Disease Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Rare Disease Drug Capacity Production and Growth Rate
Figure 2014-2019 Rare Disease Drug Production Global Market Share
Figure Rare Disease Drug Product and Specifications
Table 2014-2019 Rare Disease Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Rare Disease Drug Capacity Production and Growth Rate
Figure 2014-2019 Rare Disease Drug Production Global Market Share
Figure Rare Disease Drug Product and Specifications
Table 2014-2019 Rare Disease Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Rare Disease Drug Capacity Production and Growth Rate
Figure 2014-2019 Rare Disease Drug Production Global Market Share
Figure Rare Disease Drug Product and Specifications
Table 2014-2019 Rare Disease Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Rare Disease Drug Capacity Production and Growth Rate
Figure 2014-2019 Rare Disease Drug Production Global Market Share
Figure Rare Disease Drug Product and Specifications
Table 2014-2019 Rare Disease Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Rare Disease Drug Capacity Production and Growth Rate
Figure 2014-2019 Rare Disease Drug Production Global Market Share
Figure Rare Disease Drug Product and Specifications
Table 2014-2019 Rare Disease Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Rare Disease Drug Capacity Production and Growth Rate
Figure 2014-2019 Rare Disease Drug Production Global Market Share
Table 2014-2019 Global Rare Disease Drug Capacity List
Table 2014-2019 Global Rare Disease Drug Key Manufacturers Capacity Share List
Figure 2014-2019 Global Rare Disease Drug Manufacturers Capacity Share
Table 2014-2019 Global Rare Disease Drug Key Manufacturers Production List
Table 2014-2019 Global Rare Disease Drug Key Manufacturers Production Share List
Figure 2014-2019 Global Rare Disease Drug Manufacturers Production Share
Figure 2014-2019 Global Rare Disease Drug Capacity Production and Growth Rate
Table 2014-2019 Global Rare Disease Drug Key Manufacturers Production Value List
Figure 2014-2019 Global Rare Disease Drug Production Value and Growth Rate
Table 2014-2019 Global Rare Disease Drug Key Manufacturers Production Value Share List
Figure 2014-2019 Global Rare Disease Drug Manufacturers Production Value Share
Table 2014-2019 Global Rare Disease Drug Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Rare Disease Drug Production
Table 2014-2019 Global Supply and Consumption of Rare Disease Drug
Table 2014-2019 Import and Export of Rare Disease Drug
Figure 2018 Global Rare Disease Drug Key Manufacturers Capacity Market Share
Figure 2018 Global Rare Disease Drug Key Manufacturers Production Market Share
Figure 2018 Global Rare Disease Drug Key Manufacturers Production Value Market Share
Table 2014-2019 Global Rare Disease Drug Key Countries Capacity List
Figure 2014-2019 Global Rare Disease Drug Key Countries Capacity
Table 2014-2019 Global Rare Disease Drug Key Countries Capacity Share List
Figure 2014-2019 Global Rare Disease Drug Key Countries Capacity Share
Table 2014-2019 Global Rare Disease Drug Key Countries Production List
Figure 2014-2019 Global Rare Disease Drug Key Countries Production
Table 2014-2019 Global Rare Disease Drug Key Countries Production Share List
Figure 2014-2019 Global Rare Disease Drug Key Countries Production Share
Table 2014-2019 Global Rare Disease Drug Key Countries Consumption Volume List
Figure 2014-2019 Global Rare Disease Drug Key Countries Consumption Volume
Table 2014-2019 Global Rare Disease Drug Key Countries Consumption Volume Share List
Figure 2014-2019 Global Rare Disease Drug Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Rare Disease Drug Consumption Volume Market by Application
Table 89 2014-2019 Global Rare Disease Drug Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Rare Disease Drug Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Rare Disease Drug Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Rare Disease Drug Consumption Volume Market by Application
Figure 2019-2024 Global Rare Disease Drug Capacity Production and Growth Rate
Figure 2019-2024 Global Rare Disease Drug Production Value and Growth Rate
Table 2019-2024 Global Rare Disease Drug Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Rare Disease Drug Production
Table 2019-2024 Global Supply and Consumption of Rare Disease Drug
Table 2019-2024 Import and Export of Rare Disease Drug
Figure Industry Chain Structure of Rare Disease Drug Industry
Figure Production Cost Analysis of Rare Disease Drug
Figure Downstream Analysis of Rare Disease Drug
Table Growth of World output, 2014 - 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 - March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Rare Disease Drug Industry
Table Rare Disease Drug Industry Development Challenges
Table Rare Disease Drug Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Rare Disease Drugs Project Feasibility Study


More Publications